buprenorphine 2 MG / naloxone 0.5 MG Sublingual Film [Suboxone]
buprenorphine
RxCUI: 1010603
What the CMS Formulary Data Shows for buprenorphine 2 MG / naloxone 0.5 MG Sublingual Film [Suboxone]
Per the CMS 2026 Part D formulary file, buprenorphine 2 MG / naloxone 0.5 MG Sublingual Film [Suboxone] (RxNorm concept RXCUI 1010603, generic name buprenorphine) appears on 8 distinct formulary files spanning 843 Medicare Part D plan offerings - 16.6% of enrollable Part D products, selective placement; verify formulary inclusion before enrolling. Tier placement ranges from Tier 1 to Tier 4, with a cross-plan average of Tier 3.3.
Real-world access to buprenorphine 2 MG / naloxone 0.5 MG Sublingual Film [Suboxone] depends on utilization management as much as tier placement: 0% of covering formularies require prior authorization. 0% require step therapy. 25% apply quantity limits.
Historical spending context from the CMS Medicare Part D Drug Spending Dashboard shows 74,893 Part D beneficiaries filled buprenorphine 2 MG / naloxone 0.5 MG Sublingual Film [Suboxone] in 2023, with total plan-and-beneficiary spending of $119,900,450 and an average per-beneficiary annual cost of $1,600.96. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry buprenorphine 2 MG / naloxone 0.5 MG Sublingual Film [Suboxone] today.
Coverage Details
- Formularies covering
- 8
- Plans covering
- 843
- Coverage rate
- 16.6%
- Tier range
- Tier 1 – Tier 4
- Average tier
- Tier 3, Preferred Brand
Restrictions
- Prior authorization required
- 0% of formularies
- Step therapy required
- 0% of formularies
- Quantity limits
- 25% of formularies
2023 Medicare Spending
- Beneficiaries
- 74,893
- Total spending
- $119,900,450
- Avg per beneficiary
- $1,600.96
Tier Distribution Across Plans
Standalone Drug Plans (PDP) Covering buprenorphine 2 MG / naloxone 0.5 MG Sublingual Film [Suboxone]
5 standalone prescription drug plans include this drug.
| Plan | Insurer | Tier | PA | ST | Premium | States |
|---|---|---|---|---|---|---|
| AARP Medicare Rx Preferred from UHC (PDP) | UNITEDHEALTHCARE INS. CO. & UHC INS. CO. OF NY | T4 | No | No | $0 | - |
| AARP Medicare Rx Preferred from UHC (PDP) | UNITEDHEALTHCARE INS. CO. & UHC INS. CO. OF NY | T4 | No | No | $0 | - |
| AARP Medicare Rx Saver from UHC (PDP) | UNITEDHEALTHCARE INS. CO. & UHC INS. CO. OF NY | T4 | No | No | $0 | - |
| AARP Medicare Rx Saver from UHC (PDP) | UNITEDHEALTHCARE INS. CO. & UHC INS. CO. OF NY | T4 | No | No | $0 | - |
| AARP Medicare Rx Saver from UHC (PDP) | UNITEDHEALTHCARE INS. CO. & UHC INS. CO. OF NY | T4 | No | No | $0 | - |
Medicare Advantage Plans (MA-PD) Covering buprenorphine 2 MG / naloxone 0.5 MG Sublingual Film [Suboxone]
95 Medicare Advantage plans with Part D drug coverage include this drug.
Frequently Asked Questions
Is buprenorphine 2 MG / naloxone 0.5 MG Sublingual Film [Suboxone] covered by Medicare Part D?
Yes, buprenorphine 2 MG / naloxone 0.5 MG Sublingual Film [Suboxone] is covered by 843 Medicare Part D plans (16.6% of all Part D formularies).
What tier is buprenorphine 2 MG / naloxone 0.5 MG Sublingual Film [Suboxone] on Medicare Part D plans?
buprenorphine 2 MG / naloxone 0.5 MG Sublingual Film [Suboxone] averages Tier 3.3 across Part D plans, ranging from Tier 1 to Tier 4.
Does buprenorphine 2 MG / naloxone 0.5 MG Sublingual Film [Suboxone] require prior authorization?
0% of Part D formularies require prior authorization for buprenorphine 2 MG / naloxone 0.5 MG Sublingual Film [Suboxone]. Step therapy: 0%. Quantity limits: 25%.
How much does Medicare spend on buprenorphine 2 MG / naloxone 0.5 MG Sublingual Film [Suboxone]?
In 2023, total Medicare Part D spending on buprenorphine 2 MG / naloxone 0.5 MG Sublingual Film [Suboxone] was $119,900,450, covering 74,893 beneficiaries. The average spend per beneficiary was $1,600.96.
Read our methodology - how this data is sourced, computed, and verified.